Has Matthew Steinway, MD received payments from drug or device companies?

Yes. Drug and device makers reported $22,796 in general payments to Matthew Steinway, MD across 690 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Steinway, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Steinway, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Steinway, MD

Urology · Scottsdale, AZNPI 1346454246

Payments from drug & device makers

$22,796in general payments, 2019–2025

Across 690 payments — averaging $33.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alnylam Pharmaceuticals Inc.$5K
Boston Scientific$1K
Dendreon Pharmaceuticals LLC$1K
Johnson & Johnson$1K
Histosonics, Inc.$1K
Pfizer$1K
plus $12K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alnylam Pharmaceuticals Inc.	9	$4,963
Boston Scientific	18	$1,499
Dendreon Pharmaceuticals LLC	76	$1,341
Johnson & Johnson(2 entities)	41	$1,108
Histosonics, Inc.	2	$1,050
Pfizer	50	$1,008
Teleflex LLC	15	$800
Antares Pharma, Inc.	69	$715
Astellas Pharma US Inc	39	$662
Progenics Pharmaceuticals, Inc.	26	$632
Intuitive Surgical	6	$621
Sumitomo Pharma America, Inc.	13	$573
Coloplast	43	$573
Procept Biorobotics Corporation	6	$552
AbbVie(2 entities)	29	$519
Blue Earth Diagnostics	21	$487
Myriad Genetic Laboratories, Inc.	17	$468
Bayer	17	$437
Calyxo, Inc.	5	$377
Endo Pharmaceuticals Inc.	21	$362
Merck	14	$346
Urogen Pharma, Inc.	18	$343
180 Medical, Inc.	14	$328
Ferring Pharmaceuticals Inc.	17	$327
Accord Healthcare, Inc.	3	$239
Neotract Inc.	6	$203
Halozyme Inc	24	$198
Stryker	2	$169
Endo USA, Inc.	5	$164
Storz Medical America, Inc.	1	$143
Innovation Technologies Inc	2	$141
Angiodynamics, Inc.	1	$141
Portola Pharmaceuticals, LLC	1	$128
Novartis	7	$123
Olympus America Inc.	5	$85
C. R. Bard, Inc. & Subsidiaries	4	$83
Ambu Inc.	4	$81
Tolmar Pharmaceuticals, Inc.	3	$65
AstraZeneca	3	$63
Sun Pharmaceutical Industries Inc.	3	$55
Conmed Corporation	1	$50
Axonics, Inc.	3	$48
Tolmar, Inc.	3	$47
Vertex	2	$47
KARL Storz Endoscopy-america	1	$45
Profound Medical Corp.	1	$38
Hollister Incorporated	2	$32
Medtronic	1	$29
Davol Inc.	1	$28
Abbott	1	$22
Avadel Specialty Pharmaceuticals, LLC	1	$22
Tempus AI, Inc	1	$21
Osiris Therapeutics Inc.	1	$20
Inspire Medical Systems, Inc.	1	$19
Rochester Medical Corporation	1	$18
Immunitybio, Inc.	1	$18
Urovant Sciences Inc	1	$17
Myovant Sciences Inc.	1	$17
Foundation Medicine, Inc.	1	$16
Bioprotect Medical, Inc.	1	$15

How this compares

$22,796 in reported general payments places this provider in the 85th percentile of 269 urology providers in Arizona.

See all urology providers in Arizona →

Medicare billing

Part B allowed, 2024

$513,886

Medicare patients

1,006

Services billed

7,190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Scottsdale

Mark TysonScottsdale$4.9M
Michael ZellScottsdale$64K
Thayne LarsonScottsdale$48K
Aqsa KhanScottsdale$36K
Jackson CaboScottsdale$36K
Anojan NavaratnamScottsdale$30K
Bernard GburekScottsdale$27K
Kelli GrossScottsdale$21K
James DaitchScottsdale$16K
Daniel FrendlScottsdale$15K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →